Angiotech - Redefining Success™
Search
  • About Us
    • Corporate Profile
    • Company History
    • Management Team
    • Intellectual Property
  • Products
    • Product Overview
    • Quill™ device
    • 5FU - CVC
    • Interventional
    • Biopsy
    • Ophthalmic
    • Surgical
    • Angiotech Partner Solutions
    • Private Label
  • Healthcare Professionals
    • About...
  • Investors
    • Investor Overview
    • Corporate Governance
    • Events & Webcasts
    • Quarterly Results
    • Proxy Materials
    • SEC Filings
  • News
    • Press Releases
    • Email Alerts
  • Careers
  • Contact Us

 Investor Overview

Print

Home › Investor Overview

As of May 2013, Angiotech will no longer be a voluntary filer of its financial information with the U.S. Securities and Exchange Commission, and going forward Angiotech will be a fully private company. If you are a current Angiotech shareholder and have questions, or you would like to receive our most recent quarterly financial information, please email ir@angio.com with your name and the name of your agent, if applicable. Please be advised that we will ONLY send information to current shareholders, and only to the address as provided on the current share registry at the time of the mailing.

This information is intended for investors. Please read our website's Terms of Use.

Welcome to Angiotech's Investor Relations section. Use the navigation menu on the left to find up-to-date corporate financial information. Some other helpful links include:

  • Earnings Reports
  • Events and Webcasts
  • Company Information
  • Press Releases

Important Financial Release Dates

  • Q1 : Tuesday, May 15, 2012
  • Q2 : Wednesday, August 15, 2012
  • Q3 : Thursday, November 15, 2012
  • Q4 and Year End : TBA

Investor Relations Contacts

Investors, security analysts and representatives of portfolio management firms may contact:

  • tel: (604) 221-7933
  • email: ir@angio.com.

Investors

  • Investor Overview
  • Corporate Governance
  • Events & Webcasts
  • Quarterly Results
  • Proxy Materials
  • SEC Filings

Quick Links

  • Product Overview
  • Events & Webcasts
  • Latest Quarterly Results
  • Press Releases

Home

  • Terms of Use
  • Privacy Policy
  • Contact Us
  • Careers

About Us

  • Corporate Profile
  • Company History
  • Management Team
  • Intellectual Property

Products

  • Product Overview
  • Quill™ device
  • 5FU - CVC
  • Interventional
  • Biopsy
  • Ophthalmic
  • Surgical
  • Angiotech Partner Solutions
  • Private Label

Investors

  • Investor Overview
  • Corporate Governance
  • Events & Webcasts
  • Quarterly Results
  • Proxy Materials
  • SEC Filings

News

  • Press Releases
  • Email Alerts

© Copyright 2011 Angiotech. All Rights Reserved.